Form 4: Dentsply Sirona Director Jonathan Mazelsky Reports Acquisition of Common Stock and Phantom Stock

Jonathan Mazelsky, a director at Dentsply Sirona, reported the acquisition of common stock and phantom stock through dividend accruals.

Summary

• On July 12, 2024, Jonathan Mazelsky, a director of Dentsply Sirona Inc. [XRAY], acquired 86.725 shares of common stock at $0 per share due to dividends on restricted stock units (RSUs).
• Mazelsky also acquired 21.5597 shares of phantom stock due to accrued dividends.
• Following these transactions, Mazelsky beneficially owns 13,588.874 shares of common stock and 3,497.975 shares of phantom stock.
• The phantom stock is the economic equivalent of common stock and becomes payable upon termination of service as a director.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to director compensation, indicating a neutral to slightly positive sentiment as it shows continued investment in the company.

Positives

• The acquisition of common stock through dividends on RSUs indicates a continued investment in the company by the director.
• The acquisition of phantom stock through accrued dividends further aligns the director's interests with the long-term performance of the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The reported transactions provide transparency to shareholders regarding the director's stake in the company.
• The acquisition of stock and phantom stock aligns the director's interests with those of the shareholders.

Key Dates